Abbott India Limited

NSE ABBOTINDIA.NS

Abbott India Limited Current Liabilities for the year ending March 31, 2024: USD 160.98 M

Abbott India Limited Current Liabilities is USD 160.98 M for the year ending March 31, 2024, a 9.71% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Abbott India Limited Current Liabilities for the year ending March 31, 2023 was USD 146.74 M, a -7.40% change year over year.
Abbott India Limited Current Liabilities for the year ending March 31, 2022 was USD 158.46 M, a 12.56% change year over year.
Abbott India Limited Current Liabilities for the year ending March 31, 2021 was USD 140.78 M, a 19.06% change year over year.
Abbott India Limited Current Liabilities for the year ending March 31, 2020 was USD 118.25 M, a -4.10% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

NSE: ABBOTINDIA.NS

Abbott India Limited

CEO	Mr. Sridhar Kadangode
IPO Date	Aug. 12, 2002
Location	India
Headquarters	Godrej BKC
Employees	3,814
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Key trends

Past 5 years